Clinical Trial Update: COMT Polymorphism and Entacapone Efficacy [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing whether COMT gene polymorphisms influence the efficacy of entacapone in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Entacapone (Entacapone)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Parkinson's Disease | Phase 4 | Status: COMPLETED